TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012
TCL Archive Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs August 18, 1995
TCL Archive Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review January 13, 1978